368 related articles for article (PubMed ID: 27566613)
1. Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.
Mohamed AI; Omar MA; Hammad MA; Mohamed AA
J Fluoresc; 2016 Nov; 26(6):2141-2149. PubMed ID: 27566613
[TBL] [Abstract][Full Text] [Related]
2. Determination of the anti-viral drug Ribavirin in dosage forms via micelle-enhanced spectrofluorimetric method.
Alarfaj NA; El-Tohamy MF
Luminescence; 2013; 28(2):190-4. PubMed ID: 22473851
[TBL] [Abstract][Full Text] [Related]
3. Stability-indicating micelle-enhanced spectrofluorimetric method for determination of loratadine and desloratadine in dosage forms.
Walash MI; Belal F; El-Enany N; Eid M; El-Shaheny RN
Luminescence; 2011; 26(6):670-9. PubMed ID: 21491578
[TBL] [Abstract][Full Text] [Related]
4. Micelle-enhanced spectrofluorimetric method for determination of sitagliptin and identification of potential alkaline degradation products using LC-MS.
Salim MM; El-Enany N; Belal F; Walash M; Patonay G
Luminescence; 2014 Feb; 29(1):65-73. PubMed ID: 23559485
[TBL] [Abstract][Full Text] [Related]
5. Stability-indicating micellar enhanced spectro-fluorometric determination of Daclatasvir in its tablet and spiked human plasma.
Sultan MA; Abou El-Alamin MM; Wark AW; Azab MM
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Mar; 211():52-58. PubMed ID: 30503988
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous spectrofluorimetric determination of amlodipine besylate and valsartan in their combined tablets.
Shaalan RA; Belal TS
Drug Test Anal; 2010 Oct; 2(10):489-93. PubMed ID: 20872895
[TBL] [Abstract][Full Text] [Related]
7. Micelle-enhanced spectrofluorimetric method for determination of cholesterol-reducing drug ezetimibe in dosage forms.
Alarfaj NA; Aly FA
J Fluoresc; 2012 Jan; 22(1):9-15. PubMed ID: 21858740
[TBL] [Abstract][Full Text] [Related]
8. An eco-friendly stability-indicating spectrofluorimetric method for the determination of two anticancer stereoisomer drugs in their pharmaceutical preparations following micellar enhancement: Application to kinetic degradation studies.
El-Kimary EI; El-Yazbi AF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jun; 163():145-53. PubMed ID: 27045788
[TBL] [Abstract][Full Text] [Related]
9. Spectrofluorimetric and micelle-enhanced spectrofluorimetric methods for determination of Felodipine and Nimodipine in pharmaceutical preparations and human plasma.
Mohamed AM; Omar MA; Hammad MA; Mohamed AA
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 149():934-40. PubMed ID: 26005990
[TBL] [Abstract][Full Text] [Related]
10. Micelle-enhanced spectrofluorimetric method for determination of lacidipine in tablet form; application to content uniformity testing.
Belal F; Sharaf El-Din M; Tolba MM; Alaa H
Luminescence; 2015 Sep; 30(6):805-11. PubMed ID: 25504545
[TBL] [Abstract][Full Text] [Related]
11. Second-derivative synchronous spectrofluorimetric determination of nebivolol hydrochloride and amlodipine besylate in their combined dosage form.
Ibrahim F; El-Enany N; Shalan SH; Abo Shabana RA
Luminescence; 2015 Nov; 30(7):1011-9. PubMed ID: 25727077
[TBL] [Abstract][Full Text] [Related]
12. Steady-state and synchronous spectrofluorimetric methods for simultaneous determination of aliskiren hemifumarate and amlodipine besylate in dosage forms.
Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
Luminescence; 2014 Nov; 29(7):878-83. PubMed ID: 24687516
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets.
Hassan SA; Elzanfaly ES; El-Zeany SB; Salem MY
Acta Pharm; 2016 Dec; 66(4):479-490. PubMed ID: 27749253
[TBL] [Abstract][Full Text] [Related]
14. Micelle-enhanced spectrofluorimetric method for determination of cyproheptadine hydrochloride in tablets: application to in-vitro drug release and content uniformity test.
Belal F; El-Din MK; Tolba MM; Elmansi H
J Fluoresc; 2014 Jan; 24(1):85-91. PubMed ID: 23900846
[TBL] [Abstract][Full Text] [Related]
15. New methods for amlodipine and valsartan native spectrofluorimetric determination, with factors optimization study.
El-Kosasy AM; Tawakkol SM; Ayad MF; Sheta AI
Talanta; 2015 Oct; 143():402-413. PubMed ID: 26078177
[TBL] [Abstract][Full Text] [Related]
16. Stability-indicating spectrofluorimetric method for determination of itopride hydrochloride in raw material and pharmaceutical formulations.
Walash MI; Ibrahim F; Eid MI; El Abass SA
J Fluoresc; 2013 Nov; 23(6):1293-300. PubMed ID: 23852162
[TBL] [Abstract][Full Text] [Related]
17. Stability-Indicating Spectrofluorimetric Methods for the Determination of Metolazone and Xipamide in Their Tablets. Application to Content Uniformity Testing.
Walash MI; El-Enany N; Eid MI; Fathy ME
J Fluoresc; 2014 Mar; 24(2):363-76. PubMed ID: 24091803
[TBL] [Abstract][Full Text] [Related]
18. Validated spectrofluorometric methods for determination of amlodipine besylate in tablets.
Abdel-Wadood HM; Mohamed NA; Mahmoud AM
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Aug; 70(3):564-70. PubMed ID: 17889593
[TBL] [Abstract][Full Text] [Related]
19. Spectrofluorimetric analysis of gemifloxacin mesylate in pharmaceutical formulations.
Al-Tamimi SA; Alarfaj NA; Aly FA; Al-Mohaimeed AM
Luminescence; 2014 Mar; 29(2):127-31. PubMed ID: 23681953
[TBL] [Abstract][Full Text] [Related]
20. Micelle-enhanced spectrofluorimetric method for quantification of entacapone in tablets and human plasma.
Belal F; Ibrahim F; Sheribah ZA; Alaa H
Luminescence; 2017 Aug; 32(5):713-722. PubMed ID: 27917581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
